Baillie Gifford & Co
BNTX icon

Baillie Gifford & Co’s BioNTech BNTX Stock Holding History

Baillie Gifford & Co’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.1M Sell
592,380
-290,192
-33% -$27.3M 0.05% 154
2026
Q1 		$78.4M Sell
882,572
-362,295
-29% -$37.2M 0.08% 131
2025
Q4 		$119M Sell
1,244,867
-6,634,492
-84% -$668M 0.1% 119
2025
Q3 		$777M Sell
7,879,359
-159,513
-2% -$17.1M 0.58% 34
2025
Q2 		$856M Sell
8,038,872
-120,810
-1% -$12.2M 0.64% 31
2025
Q1 		$743M Sell
8,159,682
-60,899
-0.7% -$6.82M 0.65% 32
2024
Q4 		$937M Sell
8,220,581
-87,490
-1% -$9.98M 0.72% 34
2024
Q3 		$987M Buy
8,308,071
+31,773
+0.4% +$2.92M 0.74% 34
2024
Q2 		$665M Sell
8,276,298
-82,641
-1% -$7.55M 0.52% 43
2024
Q1 		$771M Sell
8,358,939
-330,243
-4% -$31.7M 0.6% 41
2023
Q4 		$917M Buy
8,689,182
+86,343
+1% +$8.7M 0.73% 36
2023
Q3 		$935M Buy
8,602,839
+1,152,541
+15% +$127M 0.85% 31
2023
Q2 		$804M Sell
7,450,298
-90,614
-1% -$10.2M 0.68% 37
2023
Q1 		$939M Sell
7,540,912
-177,211
-2% -$24.3M 0.85% 28
2022
Q4 		$1.16B Buy
7,718,123
+473,051
+7% +$72.8M 1.21% 22
2022
Q3 		$977M Sell
7,245,072
-17,908
-0.2% -$2.74M 1.01% 27
2022
Q2 		$1.08B Buy
7,262,980
+518,283
+8% +$79.2M 1.11% 25
2022
Q1 		$1.15B Buy
6,744,697
+212,261
+3% +$35.7M 0.81% 30
2021
Q4 		$1.68B Buy
6,532,436
+187,123
+3% +$51.2M 0.92% 30
2021
Q3 		$1.73B Sell
6,345,313
-84,436
-1% -$26.8M 0.91% 29
2021
Q2 		$1.44B Sell
6,429,749
-308,263
-5% -$58.1M 0.7% 37
2021
Q1 		$736M Buy
+6,738,012
New +$716M 0.41% 62

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Baillie Gifford & Co's BNTX Position: Q2 2026 in Review

Baillie Gifford & Co reduced its BioNTech (BNTX) stake by 33% in Q2 2026, selling an estimated $27.3M and leaving 592,380 shares worth $55.1M. The position accounts for 0.05% of the portfolio, ranked #154.

Baillie Gifford & Co first reported a position in BNTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.73B in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Baillie Gifford & Co held 592,380 shares of BioNTech worth $55.1M as of Q2 2026.
  • Baillie Gifford & Co sold 290,192 BioNTech shares in Q2 2026, an estimated $27.3M.
  • BioNTech made up 0.05% of Baillie Gifford & Co's portfolio in Q2 2026, its #154 holding.
  • Baillie Gifford & Co first reported a position in BioNTech in Q1 2021 and has held it in 22 quarters since.
  • Baillie Gifford & Co's BioNTech position peaked at $1.73B in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.